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Abstract: The potential of marine natural products to become new drugs is vast; however, research
is still in its infancy. The chemical and biological diversity of marine toxins is immeasurable and
as such an extraordinary resource for the discovery of new drugs. With the rapid development
of next-generation sequencing (NGS) and liquid chromatography–tandem mass spectrometry
(LC-MS/MS), it has been much easier and faster to identify more toxins and predict their functions
with bioinformatics pipelines, which pave the way for novel drug developments. Here we provide
an overview of related bioinformatics pipelines that have been supported by a combination of
transcriptomics and proteomics for identification and function prediction of novel marine toxins.
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1. Introduction
A variety of biological activities have been identified in venoms, including neurobiological,
enzymatic, cytotoxic, antibacterial, agglutination, hemolytic, anti-thrombus, coagulation, immunoregulatory,
enzyme immune, and antiviral activities [1–5]. A typical example is that each subtype of Na+, K+,
Ca2+ or Cl− ion channels in almost all animals has its interactional venom peptides or proteins from
different venomous species [6].
Marine venoms have been largely ignored as a source for potential pharmaceuticals, despite
research suggesting that there are more marine venomous species than all other venomous terrestrial
animals combined [7]. Little is known about the composition of marine venoms and, consequently,
these venoms present a unique source of novel drugs and pharmacological tools. Bioassay-guided
fractionation has been traditionally used for marine venom analysis [8]. However, this approach
is considered time-consuming and requires large amounts of crude venoms, which are not always
available. The extraction of venoms from the venom gland tissues is also troublesome as marine
venoms have been shown to be highly labile and sensitive to heat, changes in pH, lyophilization,
storage or repeated freeze-thaw cycles [9]. Marine venom samples are typically mucus-rich, causing
immense difficulty during proteomic methodologies. The collection of fish venoms has proven to be
the most difficult issue as the venom glands are typically deeply embedded in the skin or muscle of the
venom apparatus, and it is impractical to remove the venom gland without interfering with peripheral
tissues (Figure 1).
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located  in  their pectoral and dorsal  fins. As shown  in  the right enlarged  image, venom spines are 
typically composed of spine (A), connective tissue (B) and venom gland (C). 
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as  a  consequence,  these  data  show  up  in  the  peer‐reviewed  literature  rather  than  in  generalist 
databases.  In contrast, most sequences  in  toxin‐centered databases have been well annotated and 
peer‐reviewed [8]. The Tox‐prot Program [15], the Animal Toxin Database (ATDB) [16], ConoServer 
[17],  ArachnoServer  [18,19],  and  ISOB  (Indigenous  Snake  species  Of  Bangladesh, 
http://www.snakebd.com/) provide expert annotations on sequences and 3D structures of general 
venomous animals [16,19–22]. Sequences from these toxin‐specific databases can be easily traced back 
to  the  original  peer‐reviewed  papers  or  found  in  the  generalist  databases.  Databases  such  as 
Conoserver  and  ArchnoServer  are  good  at  addressing  the  problem  of  nomenclature  of  newly 
identified toxins [23,24]. 








general  databases,  such  as NCBI‐RefSeq, NCBI‐nucleotide,  UniProtKB/Swiss‐Prot  and  TrEMBL, 
Figure 1. Morphology of venom glands in a scorpionfish. For venom fish, venom glands are usually
located in their pectoral and dorsal fins. As shown in the right enlarged image, venom spines are
typically composed of spine (A), connective tissue (B) and venom gland (C).
Multi-omics studies using next-generation sequencing (NGS) and liquid chromatography-tandem
mass sp ctrometry (LC-MS/MS) technologies advanced consi erably, leading to more sensitive and
efficient rese rch of ve oms [10,11]. These techniques have been proven to be successful in several
fields, such as neuroendocrine research and drug discovery [12]. Further, utilization of de novo
assembling algorithms for deep sequencing has been widely applied in large-scale genomic and
transcriptomic sequencing projects, with accurate assembly of fragment data into full-length transcripts,
in particular in the absence of a reference genome sequence [13].
In this review, e access the current state of knowledge regarding marine venoms, in particular
how toxin databases can be correctly utilized in order to accurately predict function f marine toxins.
2. Toxin Database
There a two kinds of toxin databases, generalist and toxi -centered. In g neralist dat bases such
as Genbank (a collection of all publicly available sequences), it is difficult o extract the toxin sequences
or th ir structure data due to a lack of annotations as toxi s r the redundancy f similar sequences [11,14].
Large amounts of toxin infor ation have been sub i ted along with publ cations; as a consequence,
these data show up in peer-reviewed literature rather than in generalist d abases. In contrast,
most sequences in toxin-centered databa es have be w ll annot t d and peer-reviewed [8]. The
Tox-prot Program [15], the Animal Toxin D tabase (ATDB) [16], C noServer [17], rachnoServer [18,19],
and ISOB (Indigenous Snake species Of Bangladesh, http://www.snakebd.com/) provide expert
annotations on sequences and 3D structures of general ve omous animal [16,19–22]. Seq ences from
these toxin-specific databases can b easily traced back to the original peer-reviewed papers o found
in the generalist databases. Databases such as C noserver and ArchnoServer are good at addressing
the problem of nomenclature of newly identified toxins [23,24].
A complete a d well-annotated sequence provides the ultimate resource for venomics approaches;
however, this reli s on the accuracy of toxin sequences from a giv n database in rder to predict if
the sequence is a toxin or not. Toxin sequences share many imilarities in their s quences, furthe
increasing the difficulty i accurately an tating the sequence .
Aft r a bri f urvey of related publi ations and these above-m ntio ed public databases, we found
that unlike the databa es for venom rrestrial nimals (i.e., scorpions, spiders an snakes), there i no
such ique toxin database or dataset for marin v nomous species xcept cone snails (ConoServer
Database), which is a major drawback in th research of marine venoms [25]. De ite general databases,
such as NCBI-RefSeq, NCBI-nu leotide, UniProtKB/Swiss-Prot and TrEMBL, being available, toxin
and non-toxin sequ nces are combined, making it difficult to extract the required sequences. hese
difficulties make alignment work redundant and time-consuming. However, a comprehensive in-house
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database has been constructed [7] to cover currently annotated toxin sequences of reported venomous
species (Table 1).
Table 1. Summary of sequence number in our achieved toxin database (updated in January 2017).




Cone snails Conus 3860






Sea stars Asteroidea 8
Hydra Hydroida 14
Worms Cerebratulus 5
Forg, Toad Amphibia 85
Sea-urchin Echinoidea 2
Sea hare Aplysiomorpha 44
Scolopendra Myriapoda 49
All Metazoa 9688
Our in-house toxin database is a comprehensive dataset of all public toxin sequences, which
enables the discovery and annotation of toxin genes. There were 4455 toxin sequences identified
from venomous marine animals, 87% of which were from cone snails (Table 1). Considering the
remarkable research done on cone snails, it is not surprising that the majority of sequences came from
these species. However, it highlights the insignificant number of sequences from other venomous
marine species that have been discovered. There are still many obstacles to overcome this scarcity of
sequences on venomous marine species. For example, traditional annotation strategies using Blast2Go
and other programs in order to annotate assembled sequences are unsuccessful in many cases due
to rare homologs of toxins present in public databases. This issue hence complicates creation of
bioinformatics pipelines.
3. Venom-Gland Transcriptomics
Due to the dramatic decline of the cost for NGS sequencing, there are a large number of transcriptomes
available for snakes, spiders, scorpions and many other terrestrial venomous animals. Except for the
identification of novel biological active toxins, evolution/diversities of toxin families and discovery
for drug precursors are also included in the hottest research fields [26–28].
Related transcriptomics analysis can identify all the toxin genes transcribed under certain
biological circumstances or certain ecological environments. Transcriptomes can also provide insights
into the mechanisms and the diversity of toxins, venom synthesis and secretion, and the biological
functions of venoms. Meanwhile, comparative transcriptome analysis allows parallel examination
of the dynamic expression of all genes in a holistic manner. This contributes to understanding the
unique biological functions of the venom glands. A recent study undertaken on the venom glands
of fish shows that the glands most likely originate from the skin and the secretions from the skin are
speculated to play an important part in the skin recovery and immunity [29].
The method for the transcriptome analysis of venom glands is summarized in Figure 2, which
is modified from a standard procedure at BGI [30]. In brief, raw reads are firstly trimmed and
subsequently eliminated to remove redundant and low-quality reads, before assembling into contigs.
The functions of contig genes are further predicted by homologies extracted from public databases
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such as NCBI/Nr [31] and/or UniProtKB [32]; toxin precursors are then identified among the contigs
for further analysis and classification. Usually, these reads and contigs are required to be stored in one
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Figure 2. A standard procedure for transcriptome analysis at BGI.
Illumina sequencing platforms are the most widely used due to their high outputs and long
reads [7]. Transcriptomic sequencing is valuable for the venomous species whose de novo assembled
whole genome sequences are absent (i.e., without a reference genome). However, assembling of these
transcriptome reads is still considered challenging and should be treated with caution, since only a
few venomous genomes and/or transcriptomes are available. Currently, most related sequences are
from three snake species (Bermese python, king cobra and five-pacer viper) [33–35], two cone snails
(Conus bullatus and C. consors) [36,37], one scorpion [38], one spider [39], a honeybee [40] and parasitic
wasps [41].
For the majority of venomous marine species, the parameters for assembly software should be
carefully scrutinized. Generally speaking, the assembling strategy will vary for different species,
since the guanine-cytosine (GC) content, N50, and the mean length for evaluating the quality of
assembly will always be various in different species. Different assembly softwares and parameters are
often comparable and their performances are often assessed on the basis of annotation results. While
looking into the results of annotations, we always find that toxin precursors can be aligned to several
highly divergent superfamilies, which might be confusing for our subsequent analysis. We previously
observed that fish toxins belonging to any novel gene superfamily are difficult to identify using
sequence similarities due to the remote phylogenetic relationships between our examined fish and
those species in the public databases.
Reported studies have shown that hundreds of thousands of toxins may originate from only a
few primitive genes [42,43]. Scholars have reached a consensus that in the long evolutionary history of
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venomous species, only a few primitive genes have been recruited. These genes originally functioned
as non-venoms (such as hormone, proteinase inhibitor, nerve growth factor, lectin and so on) before
gradually encoding as toxin peptides or proteins under evolutionary pressure [27,44,45]. Based on
these theories and as a solution for gene annotation, profile-based alignments are more credible since
their arithmetic has been based on the position-scoring matrices of conservative sites and further
applied on a few studies for analyzing venom gland transcriptomes [7,46–48]. Profile-hidden Markov
models (pHMMS) have been recently used to identify toxin transcripts in several cone snails and fish
transcriptomes [7,46,47,49–51].
4. Venom-Gland Proteomics
Similar to those approaches for terrestrial species [25,52], proteomics approaches applied in
marine venomous animals include chromatography, electrophoresis, enzymatic digestions, Edman
degradation, and mass spectrometry (MS) [53,54].
Traditional proteomics relies largely on the use of automated Edman degradation and amino
acid composition analysis, followed by the confirmation of molecular weights. This approach enables
confident assignment of peptide sequences; however, it suffers from both low throughput and a
large amount of sample demand. However, there are typically hundreds of different peptides in the
venom of a specific venomous species [55], and therefore sequencing by Edman degradation will be
prohibitively expensive for the large number of peptides. Fortunately, in recent years, the development
of highly sensitive and high-resolution MS instruments to provide novel fragmentation techniques has
established a new solution to these issues. Most toxins are very short in sequences and hence can be
sequenced at a lower cost using tandem MS (MS/MS) [3,52,56], but Edman degradation still can be
useful as a complement to MS. For example, the latter can help to identify the isobaric amino acids
isoleucine/leucine and for N-terminal sequencing [57].
Until recently, the studies of toxic peptides from marine venomous animals have been mostly
limited by the isolation and biochemical characterization of toxins of medical importance. Little or no
attention was paid to the related genes, cellular machinery, and other important processes involved
in assembly of the final products expressed in the venoms. Marine animal venoms were generally
screened in medium- to high-throughput assays against targets of therapeutic interest, and then “hit
venoms” were chromatographically fractionated and the individual fractions were re-screened in order
to isolate peptides responsible for bioactivity. In some cases, incomplete sequence information acquired
via MS/MS and/or Edman degradation has been used for designing primers to amplify transcripts
encoding the toxin of interest from a venom gland cDNA library. This method has the advantage of
providing useful information about the signal and pro-peptide regions of the toxin precursors as well
as the sequences of transcripts encoding paralogs (and even orthologs in related species) [58].
Most of the known toxin sequences were predicted from RNA sequences with six frame-translating
or open reading frame (ORF)-finding tools. Consequently, the majority of toxins cataloged in public
databases do not have any experimental support (at protein or activity levels) for their production in
venoms. For instance, there are 1873 mature toxins recorded in Conoserver, while only 379 toxins have
experimental evidence. However, supports for mature toxin sequences are increasing rapidly with
evidence from modern proteomic experiments.
Throughout the course of evolution, venom peptides and proteins from both vertebrates and
invertebrates have been optimized to target specific receptors with high affinity and often exquisite
selectivity, making them excellent pharmacological tools and drug leads [59–61]. The number of
venom-derived peptides in preclinical or clinical trials has been increasing significantly in the past two
decades [59].
5. Combination of Transcriptomics and Proteomics
Over the past few years, there has been a rapid development in transcriptomics and proteomics
research for toxins on the basis of a combination of NGS and MS. The multi-omics analysis on a venom
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gland (i) can reveal the toxin genes under certain biological conditions or ecological environments;
(ii) can provide useful information for the scale and mechanism of the variety of toxins; (iii) and
can provide solutions to those biological questions concerning toxin functions, the process of toxin
synthesis and the secretion of toxin peptides. Meanwhile, there is a special significance for the research
targets that have never been studied before with transcriptomics analysis, which can provide evidence
for the identification of peptides and the protein mass spectrum from MS sequencing. Additionally,
the comparative analyses can verify the special biological functions between the venom glands and
other tissues (such as muscles and alimentary canals), and thus we can learn more about the process of
venom synthesis.
The integration of transcriptomic and proteomic/peptidomic approaches (Figure 3) using
bioinformatics can reveal “deep venomics” [9], which can be used to widely explore the toxins
present in venoms. Analyzing the toxin sequences with NGS cannot rely only on the basic sequence
similarities, since toxins can display high diversities. Meanwhile, skin or other tissues are always
included when extracting the venom glands due to their special connection (e.g., fish venom glands
are always embedded in the skins), and therefore toxin-like proteins (TLP) in other tissues will
influence our annotation results. Hence, proteomics will provide necessary evidence to verify these
transcripts. Now this combination method gives access to nearly complete toxin repertoires of all
single venoms, because transcript-based databases are illustrative for the certification of peptides and
protein expression profiles. Another advance of the combination of transcriptomics and proteomics is
to provide insights into the mechanisms of the diversities of toxin peptides at both the cDNA level and
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Our recent combination of transcriptomics and proteomics analyses for the Chinese Yellow
catfish [7] and the Chinese tubular cone snail [51] indicated that (i) different mature toxin sequences
can originate from one single toxin precursor by alternative splicing, insertion, premature transcription
termination, or PTMs [7,51]; (ii) large discrepancies between proteome and transcriptome data were
shown in the venom gland of Chinese yellow catfish [7]. This phenomenon was also reported in
the central American snake [2]. Interestingly, we found that sometimes toxins that are predicted
from transcriptome data cannot be supported by the proteome data. Conversely, some toxins in the
proteome have no corresponding transcripts. The source of these discrepancies may be due to the
selective expression of venom peptides or proteins from the genes [25]. Sometimes, venom samples
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for NGS are extracted from one group of samples while proteomic material is only collected from the
other group, because the quantity of venom in one venom gland is always not sufficient. There are still
some unknown types of PTMs, which may also provide reasonable explanations [25]. An alternative
theory was proposed in a recent study on the origin of the ontogenic shift in the venom content of
the Central American rattlesnake [2]: that miRNA levels are the main factor that modulates venom
composition as the relative toxin transcriptional activity was similar at all the development stages.
6. Summary
Venomous marine animals have been revealed to be an important resource for pharmacological
tools with promising biological activities. These compounds not only have novel chemical structures
but also new functions and/or functional mechanisms. In order to conduct preclinical and clinical
trials and further develop a promising lead into a marketed drug, a sustainable supply of these toxins is
necessary and challenging. For venomous fish, we are glad to launch the Fish T1K program [62] with a
project on the Comparative Genomics of Fish Venoms, which will greatly enrich our marine toxin databases
so as to overcome the obstacles from lacking reference sequences. Improvements in technologies, such
as sampling strategies, nanoscale nuclear magnetic resonance (NMR) for structure determination,
full-length chemical synthesis, data opening and exchange, and collaborations between research
groups, are all crucial for the successful development of marine toxins as drug leads. However,
a high degree of innovation in the field of marine toxins will generate a new wave of new drug
research and development in the coming future. Interdisciplinary research using new technologies
will be essential for the future success of marine toxins as new therapeutic chemical entities that
can make significant contributions to the cure of human diseases. Through the combination of
transcriptomics and proteomics, the contribution of marine toxins to the future pharmaceuticals seems
to be more promising.
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